Indian Renewable Energy Development Agency Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For IREDA, that strike is ₹105. Spot at ₹100.59 is 4.2% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for IREDA sits at ₹105, the level where option writers would experience the least aggregate loss if all open contracts were exercised at expiry. This price point acts as a magnet as the November 23 expiration approaches, drawing the underlying toward it.
Spot vs Max Pain Gap
The spot price of ₹100.59 sits about 4.2 % below the max‑pain level, indicating a downside gap that suggests the market may need upward pressure to close the distance. A narrowing of this gap would imply that buying pressure is beginning to pull the stock toward the pain point.
Shift Signal
The max‑pain figure has moved down five points from yesterday, a bearish shift that signals writers may have re‑positioned to a lower strike in anticipation of a softer rally. This downward adjustment often reflects a recalibration of hedging strategies toward a more conservative outlook.
Expiry Context
Max pain is derived from the aggregate of open call and put positions, identifying the strike where total writer loss is minimized at expiry. While historically stocks often drift toward this level in the final week, it remains a tendency—not a certainty—subject to market dynamics and news flow.
Data Note
With the spot price roughly ₹4.4 away from the max‑pain strike and 26 days left until expiry, the distance remains modest but still open to directional moves.
Data as of 2026-10-28